Form D · Other Health Care

Accriva Diagnostics Holdings, Inc.

San Diego, CA · CIK 0001505837

Offering snapshot reported Mar 11, 2015 · SEC filing

Reported sold
$15.5M
Offering amount: $18.9M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 27, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 11, 2015Initial$15,470,704No comparison3SEC filing
Apr 1, 2014Amendment$55,534,774$7,284,774vs Sep 13, 201323SEC filing
Sep 13, 2013Initial$48,250,000No comparison17SEC filing
Nov 17, 2010Initial$72,500,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-235601

Source: Form D, filed Mar 11, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tony Arnerich Director
Matt Bastardi Executive
Scott Cramer Director, Executive
William Gerber Director
Brett Giffin Executive
Noah Knauf Director
Frank La Duca Executive
James Merselis Director
Joseph Nemmers Director
John Sperzel Director, Executive
Risa Stack Director
Gregory Tibbitts Executive
Richard Wallman Director
Elizabeth Weatherman Director
Bess Weatherman Director
Tom Whalen Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
6260 Sequence Drive
San Diego, CA, 92121